Northern Trust
PRQR icon

Northern Trust’s ProQR Therapeutics PRQR Stock Holding History

Northern Trust’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$472K Sell
291,314
-3,428
-1% -$5.62K ﹤0.01% 3640
2025
Q4 		$595K Hold
294,742
– – ﹤0.01% 3598
2025
Q3 		$628K Sell
294,742
-100,037
-25% -$219K ﹤0.01% 3573
2025
Q2 		$805K Buy
394,779
+3,238
+0.8% +$5.27K ﹤0.01% 3495
2025
Q1 		$521K Sell
391,541
-25,857
-6% -$55K ﹤0.01% 3564
2024
Q4 		$1.11M Buy
417,398
+401,648
+2,550% +$1.28M ﹤0.01% 3349
2024
Q3 		$28.7K Sell
15,750
-182
-1% -$342 ﹤0.01% 4293
2024
Q2 		$26.4K Sell
15,932
-1,488
-9% -$2.89K ﹤0.01% 4303
2024
Q1 		$39.9K Hold
17,420
– – ﹤0.01% 4259
2023
Q4 		$34.5K Hold
17,420
– – ﹤0.01% 4297
2023
Q3 		$22.6K Hold
17,420
– – ﹤0.01% 4312
2023
Q2 		$28.2K Buy
17,420
+6,172
+55% +$12.1K ﹤0.01% 4342
2023
Q1 		$24K Buy
+11,248
New +$34.4K ﹤0.01% 4416
2022
Q1 		– Sell
-6,330
Closed -$51K – 4811
2021
Q4 		$51K Buy
+6,330
New +$48.2K ﹤0.01% 4588
2021
Q3 		– Sell
-13,481
Closed -$91K – 4727
2021
Q2 		$91K Sell
13,481
-4,432
-25% -$28.6K ﹤0.01% 4388
2021
Q1 		$118K Buy
+17,913
New +$91.5K ﹤0.01% 4249
2019
Q4 		– Sell
-38,742
Closed -$223K – 4288
2019
Q3 		$223K Hold
38,742
– – ﹤0.01% 3735
2019
Q2 		$353K Buy
38,742
+4,345
+13% +$51.3K ﹤0.01% 3649
2019
Q1 		$477K Sell
34,397
-7,800
-18% -$116K ﹤0.01% 3551
2018
Q4 		$666K Buy
+42,197
New +$775K ﹤0.01% 3482

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Northern Trust's PRQR Position: Q1 2026 in Review

Northern Trust reduced its ProQR Therapeutics (PRQR) stake by 1.2% in Q1 2026, selling an estimated $5.62K and leaving 291,314 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #3640.

Northern Trust first reported a position in PRQR in Q4 2018 and has held it in 20 quarters since. The position peaked at $1.11M in Q4 2024. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

  • Northern Trust held 291,314 shares of ProQR Therapeutics worth $472K as of Q1 2026.
  • Northern Trust sold 3,428 ProQR Therapeutics shares in Q1 2026, an estimated $5.62K.
  • ProQR Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3640 holding.
  • Northern Trust first reported a position in ProQR Therapeutics in Q4 2018 and has held it in 20 quarters since.
  • Northern Trust's ProQR Therapeutics position peaked at $1.11M in Q4 2024.
  • 69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.